Funds holding Livzon Pharmaceutical Group Inc
ISIN CNE0000002Y8 · China · LEI 529900Y4GWTVVTORJ443
- Fund holders
- 18
- Of which ETFs
- 11 7 other funds
- Value held
- 7.9M $ 26.7M SEK
This issuer has other securities : Livzon Pharmaceutical Group Inc (CNE100001QV5)
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND VANGUARD STAR FUNDS | 638,043 | 3.1M $ | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD EMERGING MARKETS STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 596,681 | 2.9M $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Handelsbanken Global Index Criteria Handelsbanken Fonder AB | 568,600 | 26.7M SEK | 0.02 % | as of Mar 31, 2026 ↗ |
| VANGUARD FTSE ALL-WORLD EX-US INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 101,400 | 485.7K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| JPMorgan Diversified Return Emerging Markets Equity ETF J.P. Morgan Exchange-Traded Fund Trust | 65,300 | 312.9K $ | 0.08 % | as of Apr 30, 2026 ↗ |
| VANGUARD INTERNATIONAL HIGH DIVIDEND YIELD INDEX FUND VANGUARD WHITEHALL FUNDS | 53,300 | 255.3K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 52,281 | 250.4K $ | 0.00 % | as of Apr 30, 2026 ↗ |
| Schwab Emerging Markets Equity ETF SCHWAB STRATEGIC TRUST | 51,600 | 266.5K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) China ETF SPDR INDEX SHARES FUNDS | 28,938 | 142.5K $ | 0.03 % | as of Mar 31, 2026 ↗ |
| iShares Emerging Markets Equity Factor ETF iShares, Inc. | 22,400 | 115.7K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| VANGUARD ESG INTERNATIONAL STOCK ETF VANGUARD WORLD FUND | 8,500 | 43.9K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF DBX ETF Trust | 8,262 | 42.7K $ | 0.11 % | as of Feb 27, 2026 ↗ |
| Franklin FTSE China ETF Franklin Templeton ETF Trust | 6,200 | 30.5K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| JNL Emerging Markets Index Fund JNL Series Trust | 2,900 | 14.4K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs MarketBeta Total International Equity ETF Goldman Sachs ETF Trust II | 595 | 3.1K $ | 0.00 % | as of Feb 27, 2026 ↗ |
| Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF DBX ETF Trust | 530 | 2.7K $ | 0.00 % | as of Feb 27, 2026 ↗ |
| Goldman Sachs MarketBeta Emerging Markets Equity ETF Goldman Sachs ETF Trust | 251 | 1.3K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Franklin FTSE Asia ex Japan ETF Franklin Templeton ETF Trust | 200 | 984.8 $ | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF DBX ETF Trust | 0.11 % | as of Feb 27, 2026 ↗ |
| JPMorgan Diversified Return Emerging Markets Equity ETF J.P. Morgan Exchange-Traded Fund Trust | 0.08 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) China ETF SPDR INDEX SHARES FUNDS | 0.03 % | as of Mar 31, 2026 ↗ |
| Handelsbanken Global Index Criteria Handelsbanken Fonder AB | 0.02 % | as of Mar 31, 2026 ↗ |
| Franklin FTSE China ETF Franklin Templeton ETF Trust | 0.01 % | as of Mar 31, 2026 ↗ |
| iShares Emerging Markets Equity Factor ETF iShares, Inc. | 0.01 % | as of Feb 28, 2026 ↗ |
| Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF DBX ETF Trust | 0.00 % | as of Feb 27, 2026 ↗ |
| Franklin FTSE Asia ex Japan ETF Franklin Templeton ETF Trust | 0.00 % | as of Mar 31, 2026 ↗ |
| Schwab Emerging Markets Equity ETF SCHWAB STRATEGIC TRUST | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD EMERGING MARKETS STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 0.00 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 17 | -1 | 1,637,381 | -0.2 % |
| 2026Q1 | 18 | -2 | 1,641,005 | -26.6 % |
| 2025Q4 | 20 | +1 | 2,234,905 | -1.8 % |
| 2025Q3 | 19 | -1 | 2,276,167 | -3.8 % |
| 2025Q2 | 20 | -2 | 2,365,279 | -3.7 % |
| 2025Q1 | 22 | -25 | 2,455,179 | -22.2 % |
| 2024Q4 | 47 | +2 | 3,157,554 | +13.5 % |
| 2024Q3 | 45 | -1 | 2,781,348 | -0.8 % |
| 2024Q2 | 46 | +11 | 2,802,581 | +315.3 % |
| 2024Q1 | 35 | -7 | 674,851 | -82.7 % |
| 2023Q4 | 42 | 3,904,422 |
Cite this page
Titelia. "Funds holding Livzon Pharmaceutical Group Inc". https://titelia.com/en/stocks/livzon-pharmaceutical-group-inc-CNE0000002Y8